Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,027 total articles
Diginex Limited, listed on NASDAQ under ticker DGNX, announced fiscal year 2026 financial results highlighted by 77% revenue growth to $3.6 million and a strengthened debt-free balance sheet. The company completed three strategic acquisitions—PlanA.earth GmbH, Matter DK ApS, and The Remedy Project Limited—broadening its sustainability and ESG regul…
BridgeBio Pharma, a biopharmaceutical company focused on genetic conditions, announced a secondary offering of 5 million shares of its common stock by an existing shareholder, KKR Genetic Disorder L.P. The company itself is not selling any shares and will not receive proceeds from the offering. The offering is subject to market conditions and regul…
Verizon Communications Inc. has proactively strengthened its network in Hawaii by deploying backup generators, satellite assets, and pre-staged equipment to maintain connectivity during Tropical Storm Lala. The company is collaborating with local emergency agencies and power providers to safeguard communications. Verizon also advises residents and …
REalloys Inc. reported second quarter 2026 results highlighting a $0.8 million revenue and a $36.8 million net loss driven by stock-based compensation after its Nasdaq listing. The company has fully funded a major upgrade to its SRC Rare Earth Processing Facility targeting increased annual neodymium-praseodymium (NdPr), dysprosium, and terbium oxid…
Cheetah Net Supply Chain Service Inc. reported a strong revenue increase driven by the acquisition of Super International Trading Limited, marking a strategic pivot towards international trading. Despite a rise in operating loss, the company posted net income from continuing operations for Q2 2026 due to significant foreign exchange gains and inter…
AirJoule Technologies announced its Q2 2026 earnings, emphasizing key strategic partnerships including an exclusive sales agreement with Kubota Corporation for residential water systems deployment in Texas and California, the commissioning of the first full-scale AirJoule Prime system, and multiple product deployments globally including Europe and …
Binah Capital Group, Inc. announced its financial results for Q2 2026, reporting a 13.4% year-over-year increase in Assets Under Management to $31.6 billion, a turnaround to net income of $0.3 million from a prior year net loss, and a substantial rise in EBITDA to $1.0 million. Total revenue increased by 12.1% to $46.5 million, demonstrating the co…
Satellos Bioscience Inc. reported Q2 2026 results highlighting progress in its SAT-3247 clinical trials for Duchenne muscular dystrophy (DMD). The company announced positive interim data from the adult TRAILHEAD Phase 2 study showing muscle regeneration indicators and improved quality of life. Enrollment in the pediatric BASECAMP Phase 2 study is a…
NovaBridge Biosciences announced a webcast scheduled for August 20, 2026, to discuss the company's financial results for the first half ended June 30, 2026, along with recent corporate progress. The biotechnology company focuses on therapeutic programs in oncology and ophthalmology, aiming to advance innovation through a disciplined development and…
Stardust Power Inc. announced its Q2 2026 results, highlighting ongoing progress at its Muskogee lithium refinery, including site preparations and participation in a U.S. DOE-funded lithium extraction research initiative. Despite a net loss of $3.9 million and declining cash reserves reflecting continued investment, the company strengthened liquidi…
Instil Bio, a Nasdaq-listed biotechnology company, announced its Q2 2026 financial results showing a significant reduction in net loss compared to the previous year and a strong cash position of approximately $69.9 million expected to fund operations beyond 2027. The company is exploring acquisitions and in-licensing opportunities to expand its the…
Navient's board of directors declared a third quarter dividend of $0.16 per share to be paid on September 18, 2026, reflecting the company's ongoing commitment to returning value to shareholders within the education finance and digital financial services sectors.
BIO-key International, a Nasdaq-listed biometrics and IAM company, announced Q2 2026 revenues of $1.9 million, up 13% year-over-year, with a 51% reduction in net loss. Growth was driven by increased license fee revenue and global contracts in government, defense, and financial sectors, particularly in EMEA markets. The company also raised $2.5 mill…
Skeena Resources Limited released its interim financial results for Q2 2026, highlighting progress on the Eskay Creek Gold-Silver Project in British Columbia. The fully permitted project is under construction, with initial production and cash flow expected in Q2 2027. Eskay Creek is projected to be a high-grade, low-cost open-pit precious metals mi…
Maze Therapeutics announced the addition of Paula Johnson, M.D., M.P.H., and Sophie Kornowski, Pharm.D., M.B.A., to its Board of Directors, bringing extensive clinical and biopharmaceutical experience. The appointments come as the company prepares for critical clinical data readouts and trial initiations for its kidney and metabolic disease drug ca…
Gemini Space Station, Inc. (NASDAQ: GEMI) reported strong Q2 2026 results with 37% year-over-year revenue growth to $45.5 million, driven by a 149% increase in services revenue, notably credit card and staking offerings, despite a 38% decline in exchange revenue due to softer crypto markets. The company improved operating loss sequentially by 18% t…
Winnebago Industries announced strategic manufacturing realignments, relocating key production lines to consolidate operations across its Winnebago and Grand Design RV brands. These moves aim to optimize manufacturing capacity, reduce costs, and strengthen operational coordination to fuel future growth without discontinuing any product lines or dis…
Tyson Foods announced strategic restructuring of its beef business by consolidating operations into three key facilities in Nebraska, Kansas, and Texas, closing or selling others, to address ongoing cattle supply constraints and improve competitiveness. The company plans to support impacted employees during the transition and aims to maintain stabl…
TWFG, Inc. has expanded its revolving credit facility to $125 million with an extended maturity to 2031, enhancing its liquidity and financial flexibility. The credit agreement with PNC Bank includes an uncommitted accordion feature potentially increasing borrowing capacity to $200 million. This financial move supports TWFG's growth strategy throug…
LifeVantage Corporation, a leader in health and wellness products rooted in nutrigenomics, announced that it will release its fourth quarter and full fiscal year 2026 financial results on August 27, 2026. An investor conference call and webcast will follow the release to discuss the company's performance and outlook.
CaliberCos Inc. reported second quarter 2026 financial results showing Platform Adjusted EBITDA turning positive at $0.3 million, indicating progress towards profitability. Despite a decline in platform revenue to $3.7 million, the company reaffirmed full-year 2026 guidance and highlighted major milestones including the groundbreaking of its Steamb…
Calidi Biotherapeutics announced its second quarter 2026 financial results, highlighting positive FDA pre-IND feedback on its lead candidate CLD-401, progress in its RedTail oncolytic virus platform, presentation of preclinical data for CLD-501 at ASCO 2026, board expansion with industry veteran Corsee Sanders, and a 48% reduction in general and ad…
Tempest Therapeutics announced its Q2 2026 financial results and strategic business updates, highlighting the advancement of its next-generation in vivo CAR-T platform including collaboration with Senlang Biotechnology for TPST-4003, anticipates initial clinical data in H1 2027, positive interim clinical data for TPST-2003, and corporate developmen…
CPI Aerostructures, Inc. reported substantial year-over-year improvement for Q2 and the first six months of 2026, highlighted by increased revenues, higher gross margins, and positive net income compared to losses in the prior year periods. Revenue for Q2 rose to $17.6 million from $15.2 million, with net income turning positive at $0.7 million ver…
Genelux Corporation, a clinical-stage immuno-oncology company, announced its second quarter 2026 financial results showing a net loss of $9.5 million and $18.7 million in cash reserves expected to fund operations into early 2027. The company is progressing its Olvi-Vec immunotherapy clinical trials in platinum-resistant ovarian cancer and lung canc…
